Search clinical trials for: DXP604

Total 4 results

Wuhan Institute of Biological Products Co., Ltd

Not yet recruiting

A Study to Evaluate the Efficacy and Safety of DXP604 in Patients With Mild to Moderate COVID-19

COVID-19
BeiGene

Completed

BGB-DXP604 Alone and in Combination With BGB-DXP593 in Healthy Participants

Healthy

Australia
Peking University Cancer Hospital & Institute

Completed

Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

Solid Tumor

China
Peking University Cancer Hospital & Institute

Recruiting

The Molecular Imaging Research of F-18 Labeled DX600 PET Probe

Solid Tumor

China

3

Subscribe